Antiparasitic drug
development stands as a critical endeavor in
combating infectious diseases which, by affecting the well-being of
humans, animals, and the environment, pose significant global health
challenges. In a scenario where conventional pharmacological interventions
have proven inadequate, the One Health approach, which emphasizes
interdisciplinary collaboration and holistic solutions, emerges as
a vital strategy. By advocating for the integration of One Health
principles into the R&D pharmaceutical pipeline, this Perspective
promotes green chemistry methodologies to foster the development of
environmentally friendly antiparasitic drugs for both human and animal
health. Moreover, it highlights the urgent need to address vector-borne
parasitic diseases (VBPDs) within the context of One Health-driven
sustainable development, underscoring the pivotal role of medicinal
chemists in driving transformative change. Aligned with the Sustainable
Development Goals (SDGs) and the European Green Deal, this Perspective
explores the application of the 12 Principles of Green Chemistry as
a systematic framework to guide drug discovery and production efforts
in the context of VBPD. Through interdisciplinary collaboration and
a constant commitment to sustainability, the field can overcome the
challenges posed by VBPD while promoting global and environmental
responsibility. Serving as a call to action, scientists are urged
to integrate One Health concepts and green chemistry principles into
routine drug development practices, thereby paving the way for a more
sustainable R&D pharmaceutical pipeline for antiparasitic drugs.